These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37145281)

  • 1. An Experimental Model of Chromoblastomycosis Caused by Fonsecaea sp. Species.
    Bocca AL; Siqueira IM
    Methods Mol Biol; 2023; 2667():129-138. PubMed ID: 37145281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
    Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
    Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
    Rasamoelina T; Maubon D; Andrianarison M; Ranaivo I; Sendrasoa F; Rakotozandrindrainy N; Rakotomalala FA; Bailly S; Rakotonirina B; Andriantsimahavandy A; Rabenja FR; Andrianarivelo MR; Cornet M; Ramarozatovo LS
    Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resazurin to determine the minimum inhibitory concentration on antifungal susceptibility assays for Fonsecaea sp. using a modified EUCAST protocol.
    Herman TS; da Silva Goersch C; Bocca AL; Fernandes L
    Braz J Microbiol; 2024 Jun; 55(2):1349-1357. PubMed ID: 38438831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromoblastomycosis presenting as a phagedenic ulcer on the face.
    Naveen KN; Shetty PC; Naik AS; Pai VV; Hanumanthayya K; Udupishastry D
    Int J Dermatol; 2012 May; 51(5):576-8. PubMed ID: 21923692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangitic chromoblastomycosis.
    Muhammed K; Nandakumar G; Asokan KK; Vimi P
    Indian J Dermatol Venereol Leprol; 2006; 72(6):443-5. PubMed ID: 17179621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
    Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of imiquimod as a treatment for chromoblastomycosis.
    de Sousa Mda G; Belda W; Spina R; Lota PR; Valente NS; Brown GD; Criado PR; Benard G
    Clin Infect Dis; 2014 Jun; 58(12):1734-7. PubMed ID: 24633683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.
    Machado AP; Silva MR; Fischman O
    Virulence; 2010; 1(1):29-36. PubMed ID: 21178410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis.
    Schneider GX; Gomes RR; Bombassaro A; Zamarchi K; Voidaleski MF; Costa FF; Leão ACR; Lima BJFS; Soley BS; Colombo IR; Cândido GZ; Najafzadeh MJ; Sun J; de Azevedo CMPS; Marques SG; de Hoog GS; Vicente VA
    Mycopathologia; 2019 Aug; 184(4):493-504. PubMed ID: 31317385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi.
    Zhang R; Ran Y; Zhang H; Dai Y; Ran X; Zhang C; Qin W; Xi L
    Mycopathologia; 2019 Apr; 184(2):349-352. PubMed ID: 30701405
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of chromoblastomycosis of 10-year duration due to Fonsecaea nubica.
    He L; Ma J; Mei X; Lu S; Li X; Xi L
    Mycoses; 2018 Apr; 61(4):231-236. PubMed ID: 29178398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
    Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
    Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
    Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.